Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
HZNP [NASD]
Horizon Pharma, Inc.
Index- P/E- EPS (ttm)-1.90 Insider Own0.37% Shs Outstand62.80M Perf Week0.00%
Market Cap150.72M Forward P/E- EPS next Y-0.39 Insider Trans9.42% Shs Float57.85M Perf Month-5.14%
Income-86.24M PEG- EPS next Q-0.34 Inst Own73.35% Short Float8.00% Perf Quarter13.21%
Sales26.28M P/S5.74 EPS this Y82.02% Inst Trans0.55% Short Ratio9.19 Perf Half Y-4.38%
Book/sh1.35 P/B1.78 EPS next Y54.00% ROA-50.80% Target Price5.33 Perf Year-37.17%
Cash/sh1.29 P/C1.86 EPS next 5Y20.00% ROE-103.97% 52W Range1.97 - 8.72 Perf YTD3.00%
Dividend- P/FCF- EPS past 5Y0.00% ROI-61.41% 52W High-72.48% Beta-
Dividend %- Quick Ratio2.44 Sales past 5Y- Gross Margin43.52% 52W Low21.83% ATR0.10
Employees247 Current Ratio2.55 Sales Q/Q263.50% Oper. Margin-295.39% RSI (14)44.09 Volatility3.35% 4.31%
OptionableYes Debt/Eq0.60 EPS Q/Q63.62% Profit Margin-328.15% Rel Volume0.29 Prev Close2.39
ShortableYes LT Debt/Eq0.41 EarningsMar 18 BMO Payout- Avg Volume503.75K Price2.40
Recom1.80 SMA20-0.64% SMA50-2.64% SMA200-15.30% Volume147,372 Change0.42%
07-Sep-11Initiated JMP Securities Mkt Outperform $16
17-May-13 01:04PM  HORIZON PHARMA, INC. Financials EDGAR Online Financials
10-May-13 11:54AM  Horizon Pharma CEO Discuses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
06:30AM  Horizon Pharma Announces First Quarter 2013 Financial Results and Provides Business Update Marketwired
06:30AM  Horizon Pharma Announces First Quarter 2013 Financial Results and Provides Business Update Marketwire
09-May-13 11:46PM  HORIZON PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi EDGAR Online
07:16PM  Horizon Pharma Earnings Preview: Get Ahead of the Analysts at Wall St. Cheat Sheet
29-Apr-13 07:30AM  Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results on May 10, 2013 Marketwired
07:30AM  Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results on May 10, 2013 Marketwire
12-Apr-13 08:28AM  Ask a Fool: Buffett's Biggest Misconception at Motley Fool
28-Mar-13 07:30AM  Horizon Pharma to Present at the 20th Annual Future Leaders in the Biotech Industry Conference Marketwired
07:30AM  Horizon Pharma to Present at the 20th Annual Future Leaders in the Biotech Industry Conference Marketwire
26-Mar-13 01:40PM  Whoa! These 3 Stocks Just Beat the Dow at Motley Fool
25-Mar-13 10:17AM  3 Stocks That Blew the Market Away at Motley Fool +14.29%
24-Mar-13 05:51AM  Has Horizon Pharma's Share Price Bottomed Out? at Seeking Alpha
21-Mar-13 01:04PM  HORIZON PHARMA, INC. Financials EDGAR Online Financials
18-Mar-13 12:17PM  Horizon Pharma's CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
09:27AM  Hot Stock Minute: Cyprus Surprise, Coffee Commodity Jitters Hot Stock Minute
07:11AM  Hot Stock Minute: Cyprus Surprise, Coffee Commodity Jitters Hot Stock Minute
07:07AM  Q4 2012 Horizon Pharma Inc Earnings Release - Before Market Open CCBN
06:30AM  Horizon Pharma Reports 2012 Financial Results and Provides Business Update Marketwired
06:30AM  Horizon Pharma Reports 2012 Financial Results and Provides Business Update Marketwire
17-Mar-13 11:48PM  HORIZON PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi EDGAR Online
11-Mar-13 07:30AM  Horizon Pharma to Present at the 25th Annual ROTH Conference Marketwired
07:30AM  Horizon Pharma to Present at the 25th Annual ROTH Conference Marketwire
08-Mar-13 03:15PM  4 Healthcare Stock Stories for Weekend Investor Wellness at Wall St. Cheat Sheet
07-Mar-13 07:31AM  InPlay: Horizon Pharma receives marketing authorization for DUEXIS from the United Kingdom medicines and Healthcare Products Regulatory Agency Briefing.com +10.24%
07:30AM  Horizon Pharma Receives Marketing Authorization for DUEXIS(R) From the United Kingdom Medicines and Healthcare Products Regulatory Agency Marketwire
04-Mar-13 07:30AM  Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013 Marketwire
26-Feb-13 07:30AM  Horizon Pharma to Present at the Cowen and Company 33rd Annual Health Care Conference Marketwire
11-Feb-13 12:36PM  HORIZON PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi EDGAR Online +5.19%
07:30AM  Horizon Pharma Announces Preliminary Fourth Quarter and Full Year 2012 Revenues, Full U.S. Commercial Launch of RAYOS(R) (Prednisone) Delayed-Release Tablets and Approval of LODOTRA(R) in South Korea Marketwire
06-Feb-13 07:30AM  InPlay: Horizon Pharma announces the U.S. Patent and Trademark Office issued an additional notice of allowance with claims covering RAYOS (prednisone) delayed-release tablets Briefing.com
07:30AM  Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets Marketwire
05-Feb-13 07:32AM  InPlay: Horizon Pharma announces receipt of additional U.S. Patent Allowance for DUEXIS Briefing.com +7.96%
07:30AM  Horizon Pharma Announces Receipt of Additional U.S. Patent Allowance for DUEXIS(R) Marketwire
04-Feb-13 07:30AM  Horizon Pharma to Present at the 15th Annual BIO CEO and Investor Conference Marketwire +5.61%
18-Jan-13 10:47AM  Par Pharmaceutical Sued by Horizon Over Duexis Generic at Bloomberg
09:37AM  Par Pharmaceutical Sued by Horizon Over Generic Duexis Drug at Bloomberg
21-Dec-12 03:36PM  Halozyme Partners with Pfizer, Venaxiz Seeks CE Mark for APPY1: Healthcare Business Recap at Wall St. Cheat Sheet
10:19AM  Horizon Pharma gets UK nod for arthritis drug AP
07:38AM  Horizon Pharma to receive approval from UK MHRA at theflyonthewall.com
07:30AM  InPlay: Horizon Pharma to receive approval of DUEXIS from the UK medicines and healthcare products regulatory agency Briefing.com
07:30AM  Horizon Pharma to Receive Approval of DUEXIS(R) From the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) Marketwire
19-Dec-12 07:00AM  Shorting Alexza Pharma On FDA's Adasuve Approval at TheStreet
18-Dec-12 03:08PM  Hedge Funds Are Buying These 7 Stocks at Seeking Alpha
06-Dec-12 08:07AM  4 Biotechs With Poor Balance Sheets at Seeking Alpha
05-Dec-12 01:08PM  The Worst of 2012: Horizon Pharmaceuticals at Motley Fool
04-Dec-12 04:50PM  10 Stocks With Bullish Institutional And Insider Buying Activities at TheStreet
03-Dec-12 07:06AM  Horizon Pharma begins initial commercial launch of Rayos in the U.S. at theflyonthewall.com
07:01AM  InPlay: Horizon Pharma begins initial commercial launch of RAYOS delayed-release tablets in the United States Briefing.com
07:00AM  Horizon Pharma Begins Initial Commercial Launch of RAYOS(R) (prednisone) Delayed-Release Tablets in the United States Marketwire
21-Nov-12 05:34PM  Hot Biotechs And Possible Shorting Opportunities at Seeking Alpha
17-Nov-12 01:04PM  HORIZON PHARMA, INC. Financials EDGAR Online Financials
14-Nov-12 09:27AM  New Star Analyst Rankings for Horizon Pharma, Inc. StarMine -6.50%
13-Nov-12 10:48PM  2 Speculative Biotech Plays Making Significant Strides at Seeking Alpha -5.38%
02:54PM  A Brief Bounce for This Biotech at Motley Fool
01:02PM  Horizon Pharma's CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
12:35PM  Tuesdays big movers; Sinofsky weighs on Microsoft at MarketWatch
08:00AM  Tuesdays biggest gaining and declining stocks at MarketWatch
07:07AM  Q3 2012 Horizon Pharma Inc Earnings Release - Before Market Open CCBN
07:06AM  HORIZON PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi EDGAR Online
07:02AM  Upcoming BioPharma Catalyst Trades to Consider Thomson Reuters ONE
07:00AM  Horizon Pharma Announces Third Quarter 2012 Financial Results and Provides Business Update Marketwire
12-Nov-12 05:56PM  Horizon Pharma May Be Ready For A Bounce at Seeking Alpha +13.54%
09:05AM  Horizon Pharma's RAYOS 5mg reduced morning stiffness in patients with RA theflyonthewall.com
09:04AM  5 Reasons Not to Worry This Week at Motley Fool
09:01AM  InPlay: Horizon Pharma presents clinical data demonstrating RAYOS delayed-release tablets reduce morning stiffness in patients with active rheumatoid arthritis Briefing.com
09:00AM  Horizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Morning Stiffness in Patients With Active Rheumatoid Arthritis Marketwire
11-Nov-12 07:56PM  Horizon presents data showing effectiveness of RAYOS theflyonthewall.com
09:00AM  Horizon Pharma Presents Clinical Data Demonstrating RAYOS(R) (prednisone) Delayed-Release Tablets Reduce Fatigue in Patients With Active Rheumatoid Arthritis Marketwire
09-Nov-12 09:17AM  The January Effect And 3 Biopharma Stocks at Seeking Alpha +7.51%
05-Nov-12 12:12PM  3 Things to Watch With Spectrum's Earnings at Motley Fool
07:30AM  Horizon Pharma Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets to Be Presented at the American College of Rheumatology Annual Meeting Marketwire
30-Oct-12 07:30AM  Horizon Pharma to Host Conference Call and Webcast to Discuss Third Quarter 2012 Financial Results on November 13, 2012 Marketwire
29-Oct-12 07:30AM  Horizon Pharma to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012 Marketwire
18-Oct-12 05:03PM  The Dangers of Chasing Performance in Biotech at Motley Fool
15-Oct-12 07:30AM  Horizon Pharma Announces the U.S. Patent and Trademark Office Has Issued a Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets Marketwire
09-Oct-12 01:02PM  4 Reasons To Buy Horizon Pharma at Seeking Alpha
07-Oct-12 08:29AM  Huge Insider Buy Makes This $3.50 Biopharma Stock An Intriguing Speculative Play at Seeking Alpha
04-Oct-12 02:32PM  Why Does Billionaire Thomas Steyers Farallon Love This Pharmaceutical Company? at Motley Fool
03-Oct-12 03:17PM  5 Healthcare Companies With Insider Buying During September 2012 - Part II at Seeking Alpha
01:08PM  5 Stocks Insiders Love Right Now at TheStreet
01-Oct-12 10:12PM  Horizon Beefs Up (While Burning Through Cash) at Motley Fool
07:30AM  Horizon Pharma Announces Completion of Sales Force Expansion PR Newswire
28-Sep-12 10:44AM  Friday 9/28 Insider Buying Report: HZNP, ROVI at Forbes
07:31AM  InPlay: Horizon Pharma announces receipt of two additional U.S. Patent allowances for DUEXIS Briefing.com
07:30AM  Horizon Pharma Announces Receipt of Two Additional U.S. Patent Allowances for DUEXIS® PR Newswire
27-Sep-12 09:57AM  Wild-Eyed Optimism About Horizon's Plummet at Motley Fool
07:30AM  Horizon Pharma to Present at the 11th Annual BIO Investor Forum Marketwire
26-Sep-12 11:14AM  5 of Last Week's Biggest Losers at Motley Fool
25-Sep-12 11:37AM  Horizon Pharma Announces Exercise in Full of Overallotment Option and Completion of Public Offering of Common Stock and Warrants to Purchase Common Stock Marketwire
21-Sep-12 05:12PM  These 2 Stocks Stopped the Presses at Motley Fool
05:09PM  Tang Capital reports 9.9% passive stake in Horizon Pharma theflyonthewall.com
07:39AM  Heathcare Business Recap: Dendreons Charge, Horizon Plummets at Wall St. Cheat Sheet
20-Sep-12 10:54PM  Heathcare Business Roundup: Dendreons Charge, Horizon Plummets at Wall St. Cheat Sheet -24.02%
09:54PM  Biotech Investors: Todays Big Plunge and Rally at Motley Fool
07:49PM  Heathcare Business Roundup: Dendreons Charge, Horizon Plummets at Wall St. Cheat Sheet
05:57PM  Horizon Pharma stock plunges as share sale begins AP
05:20PM  HORIZON PHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
12:45PM  Rheumatoid Arthritis, Oncology, and Hepatitis C Therapies Propel Growth in Biotech: Interview with UBS Investment Bank Expert Analyst Wall Street Transcript
Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.